- Report
- June 2018
- 315 Pages
Global
From €3326EUR$3,499USD£2,794GBP
- Report
- October 2022
- 118 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- January 2024
- 170 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- January 2025
- 84 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- December 2023
- 102 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2022
- 95 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- August 2023
- 435 Pages
Global
From €3394EUR$3,570USD£2,851GBP
- Book
- April 2009
- 1074 Pages
The Biosimulation market is a subset of the biotechnology industry that focuses on the development of computer-based models to simulate biological processes. These models are used to study the behavior of biological systems, such as the interactions between cells, organs, and organisms. Biosimulation can be used to predict the effects of drugs, understand the mechanisms of disease, and develop new treatments. It can also be used to optimize the production of biopharmaceuticals and to design new bioprocesses.
Biosimulation is a rapidly growing field, with many companies investing in the development of new technologies and applications. Companies in the market include Certara, Entelos, Simulations Plus, Schrodinger, and In Silico Biosciences. Show Less Read more